BeiGene Ltd (BGNE) reported a Q4 net loss Thursday of $1.43 per American depositary share, narrowing from $3.53 per share a year earlier.

Analysts polled by FactSet expected a loss of $1.01.

Revenue for the quarter ended Dec. 31 was $1.13 billion, up from $634.4 million a year earlier.

Analysts surveyed by FactSet expected $1.04 billion.

The company expects full year revenue between $4.9 billion and $5.3 billion.

Analysts polled by FactSet expect $4.73 billion.

BeiGene shares were up more than 3% in recent Thursday premarket activity.